A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Clinical trial NCT05885412 · RECRUITING
Trial details
- NCT number
- NCT05885412
- Sponsor
- Rocket Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-29
- Primary completion
- 2028-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.